Join us at EuroPCR 2025
Paris, Palais des Congrès, May 20-23
Don't miss the two Edwards symposia, featuring educational live cases. Explore our insightful activities at the booth and in the training village.
Tuesday 20 May
Symposium
Thursday 22 May
TAVI symposium
Stand F11, 1st floor
Palais des Congrès
Tuesday 20 May
Symposium
Pioneering innovation in the treatment of mitral and tricuspid regurgitation
Tuesday 20 May 2025 | 16:30 – 18:00
Theatre Bordeaux
Program Producer & Anchorperson: J. Hausleiter
Spokesperson: V. Rudolph
Live Centre: Cleveland Clinic London
Add to calendarSession title
To repair or to replace, that is the question
Speaker
V. Rudolph
Heart and Diabetes Center NRW - Bad Oeynhausen, Germany
Session title
Get where you want with PASCAL Precision system's maneuverability
Simulator
M. Guerrini
IRCCS Policlinico,
San Donato, Italy
Case
M. Urena
HU Paris Nord Site Bichat APHP, Paris, France
Session title
Transseptal mitral valve replacement with the SAPIEN M3 system: case presentation
Speaker
P. Lurz
University Medical Center Mainz, Mainz, Germany
Session title
To repair or to replace, that is the question
Speaker
J. Hausleiter
Klinikum der Universität München, München, Germany
Session title
Tricuspid repair with the PASCAL Precision system: case-based discussion
Speaker
D. Zemanek
General University Hospital in Prague, Prague, Czech Republic
Session title
Transcatheter Tricuspid Valve Replacement with the EVOQUE system from Cleveland Clinic London | Procedural imaging
LIVE Case
Speaker
S. Dawkins
Cleveland Clinic London Hospital, London, United Kingdom
Speaker
J. Byrne
Cleveland Clinic London Hospital, London, United Kingdom
Speaker
J. Newton
Cleveland Clinic London Hospital, London, United Kingdom
Speaker
M. Sitges
Clinical and Provincial Hospital of Barcelona, Barcelona, Spain
Session title
Session evaluation and key learnings
Speaker
J. Hausleiter
Klinikum der Universität München, München, Germany
Thursday 22 May
TAVI symposium
The impact of paravalvular leak and permanent pacemaker implantation on lifetime management in TAVI patients
Thursday 22 May 2025 | 12:30 – 14:00
Theatre Bordeaux
Program Producer & Anchorperson: S. Dawkins
Spokesperson: M. Leon
Discussants: K. Russell, M. Sitges, A. Unbehaun
Live Centre: Mainz Hospital
Add to calendarSession title
Session opening
Speaker
S. Dawkins
Cleveland Clinic London Hospital, London, United Kingdom
Session title
The relationship between PVL after TAVI, valve durability and hard outcomes
Speaker
A. Abbas
Beaumont University Hospital, Michigan, United States
Session title
The influence of PPI on medium- to long-term clinical outcomes
Speaker
L. Nai Fovino
University of Padua,
Padua, Italy
Session title
TAVI in TAVI with the SAPIEN 3 Ultra RESILIA valve from Mainz Heart Center
LIVE Case
Speaker
P. Lurz
University Medical Center Mainz, Mainz, Germany
Speaker
M. Geyer
University Medical Center Mainz, Mainz, Germany
Session title
Session evaluation and key learnings
Speaker
M. Leon
Columbia University Medical Centre, New York
The agenda is designed to provide you with the latest scientific data and practical strategies to enhance patient outcomes.
- Deepen your understanding of the impact of paravalvular leak on lifetime management.
- Explore the links between paravalvular leak, durability, and survival through compelling scientific data and a LIVE case from Mainz.
- Discover the optimal strategies to prevent or minimize the risk of paravalvular leak and permanent pacemaker implantation.
Stand F11, 1st floor
Palais des Congrès
Step into the latest Edwards transcatheter technologies at the Edwards Booth
Find us at stand F11, 1st floor, Palais des Congrès
- Explore our latest technologies
- Delve into our clinical data
- Engage in in-depth conversations about our products, including the SAPIEN 3 Ultra RESILIA valve, the PASCAL Precision system, the EVOQUE and the SAPIEN M3 systems
- Experience hands-on at our product stations
Lifetime Management Masters Sessions
Want to learn more about complex cases performed with the SAPIEN 3 Ultra RESILIA valve? Join us one of our sessions!
- Wednesday, 21 May | 10:15 – 11:00 | Edwards booth
- Thursday, 22 May | 10:30 – 11:25 | Edwards booth
We look forward to seeing you there!
Download our literature to learn more about our therapies
Explore the training village activities
with Philips, Siemens, Simulands and GE Healthcare.
To receive a summary of our EuroPCR 2025 activities, recordings, slide decks and future developments, join the Edwards Lifesciences community today.
heading 3
Content goes here
MR = mitral regurgitation; PPI = permanent pace-maker implantation; PVL = paravavular leak; TAVI = transcatheter aortic valve implantation; TR = tricuspid regurgitation.
Les informations présentées ne sont pas destinées aux professionnels de santé exerçant en France.
Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
No clinical data are available to evaluate the long-term impact of RESILIA tissue in patients. Additional clinical data for up to 10 years of follow-up are being collected to monitor the long-term safety and performance of RESILIA tissue.